Repositorio Dspace

Listar por tema "Magnetic Resonance Imaging"

Listar por tema "Magnetic Resonance Imaging"

Ordenar por:Orden:Resultados:

  • A multimodal approach to detect and monitor early lung disease in cystic fibrosis 
    Mondejar-Lopez,Pedro; Horsley,Alexander; Ratjen,Felix; Bertolo,Silvia; de-Vicente,Helene; Asensio-de-la-Cruz,Oscar (TAYLOR & FRANCIS LTD, 03/06/2021)
    Introduction: In the early stages, lung involvement in cystic fibrosis (CF) can be silent, with disease progression occurring in the absence of clinical symptoms. Irreversible airway damage is present in the early stages ...
  • Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology 
    Fernández-Velasco, Jose, I; Monreal, Enric; Kuhle, Jens; Meca-Lallana, Virginia; Meca-Lallana, José; Izquierdo, Guillermo; Oreja-Guevara, Celia; Gascon-Giménez, Francisco; de-la-Maza, Susana-Sainz; Walo-Delgado, Paulette-E; Lapuente-Suanzes, Paloma; Maceski, Aleksandra; Rodríguez-Martín, Eulalia; Roldan, Ernesto; Villarrubia, Noelia; Saiz, Albert; Blanco, Yolanda; Diaz-Pérez, Carolina; Valero-López, Gabriel; Diaz-Diaz, Judit; Aladro, Yolanda; Brieva, Luis; Iniguez, Cristina; González-Suárez, Ines; de-Antonio, Luis-ARodríguez; García-Domínguez, José-M; Sabin, Julia; Llufriu, Sara; Masjuan, Jaime; Costa-Frossard, Lucienne; Villar, Luisa-M (FRONTIERS MEDIA SA, 2022-03)
    OBJECTIVE: To ascertain the role of inflammation in the response to ocrelizumab in primary-progressive multiple sclerosis (PPMS). METHODS: Multicenter prospective study including 69 patients with PPMS who initiated ocrelizumab ...
  • Radiomics for prediction of survival in lower-grade gliomas-it's time to move beyond the crystal ball 
    Pinto-dos-Santos, Daniel; García-Santos, José-Maria (Springer Science and Business Media Deutschland GmbH, 2021)
    Radiomics might help predict survival of patients with lower-grade gliomas. Several different models using different radiomics features have been proposed with only little overlap in included features. Prospective trials ...
  • Real-world experience of ocrelizumab in multiple sclerosis in a Spanish population 
    Fernández-Diaz, Eva; Pérez-Vicente, José-Antonio; Villaverde-González, Ramón; Berenguer-Ruiz, Leticia; Candeliere-Merlicco, Antonio; Martínez-Navarro, María-Luisa; Gracia-Gil, Julia; Romero-Sánchez, Carlos-M; Alfaro-Saez, Arantxa; Diaz, Inmaculada; Giménez-Martínez, Juana; Méndez-Miralles, María-Ángeles; Millán-Pascual, Jorge; Jiménez-Pancho, Javier; Mola, Santiago; Sempere, Ángel-P (Wiley, 2021-02)
    OBJECTIVE: Pivotal trial have shown that patients with multiple sclerosis (MS) receiving ocrelizumab had better outcomes. However, data on ocrelizumab in clinical practice are limited. The aim of this study was to evaluate ...
  • Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study 
    Barrero, Francisco; Mallada-Frechin, Javier; Martínez-Gines, María-Luisa; Eugenia-Marzo, María; Meca-Lallana, Virginia; Izquierdo, Guillermo; Ramón-Ara, José; Oreja-Guevare, Celia; Meca-Lallana, José; Forero, Lucía; Sánchez-Veram, Irene; Moreno, María-José (PUBLIC LIBRARY SCIENCE, 2020-04-02)
    PURPOSE: The objective of this study was to characterize the demographic and clinical profile of RRMS patients receiving fingolimod in Spain, and to evaluate drug effectiveness and safety in clinical practice. METHODS: ...
  • Treatment of Degenerative Disc Disease with Allogeneic Mesenchymal Stem Cells: Long-term Follow-up Results 
    Noriega, David-C; Ardura, Francisco; Hernández-Ramajo, Rubén; Martín-Ferrero, Miguel-Ángel; Sánchez-Lite, Israel; Toribio, Borja; Alberca, Mercedes; García, Verónica; Moraleda, José-M; González-Vallinas, Margarita; Sánchez, Ana; García-Sancho, Javier (Lippincott Williams and Wilkins, 2021)